186 related articles for article (PubMed ID: 19569914)
1. High expression of stathmin protein predicts a fulminant course in medulloblastoma.
Kuo MF; Wang HS; Kuo QT; Shun CT; Hsu HC; Yang SH; Yuan RH
J Neurosurg Pediatr; 2009 Jul; 4(1):74-80. PubMed ID: 19569914
[TBL] [Abstract][Full Text] [Related]
2. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
4. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
6. Survivin is a negative prognostic marker in medulloblastoma.
Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
[TBL] [Abstract][Full Text] [Related]
7. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
[TBL] [Abstract][Full Text] [Related]
8. Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
Su D; Smith SM; Preti M; Schwartz P; Rutherford TJ; Menato G; Danese S; Ma S; Yu H; Katsaros D
Cancer; 2009 Jun; 115(11):2453-63. PubMed ID: 19322891
[TBL] [Abstract][Full Text] [Related]
9. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
10. [Expression of c-jun and c-fos oncogene in medulloblastoma and its clinical significance].
Li YY; Mao BY; Dong XH
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):213-5. PubMed ID: 15062038
[TBL] [Abstract][Full Text] [Related]
11. MATH-1 production by an adult medulloblastoma suggestive of a cerebellar external granule cell precursor origin.
Ueba T; Kadota E; Kano H; Yamashita K; Kageyama N
J Clin Neurosci; 2008 Jan; 15(1):84-7. PubMed ID: 18032051
[TBL] [Abstract][Full Text] [Related]
12. [An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].
Korshunov AG; Golanov AV; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 1997; (4):23-7. PubMed ID: 9460893
[TBL] [Abstract][Full Text] [Related]
13. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
de Haas T; Hasselt N; Troost D; Caron H; Popovic M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D; Baas F; Versteeg R; Kool M
Clin Cancer Res; 2008 Jul; 14(13):4154-60. PubMed ID: 18593994
[TBL] [Abstract][Full Text] [Related]
14. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma.
Hauser P; Hanzély Z; Jakab Z; Oláh L; Szabó E; Jeney A; Schuler D; Fekete G; Bognár L; Garami M
J Pediatr Hematol Oncol; 2006 Jul; 28(7):461-6. PubMed ID: 16825994
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of cyclooxygenase-2 in medulloblastoma].
Deng QJ; Mao BY; Zhang SF; Tang J; Wang ER
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):641-3. PubMed ID: 15460407
[TBL] [Abstract][Full Text] [Related]
17. [Medulloblastoma with neuronal differentiation: a report of five cases].
Nishio S; Morioka T; Inamura T; Takeshita I; Ishihara S; Fukui M
No To Shinkei; 2000 May; 52(5):391-7. PubMed ID: 10845206
[TBL] [Abstract][Full Text] [Related]
18. Development of medullomyoblastoma from classical medulloblastoma following a long term latency.
Yokoo H; Maeshima A; Sasaki A; Hirato J; Nakazato Y; Tamura M
Noshuyo Byori; 1995; 12(2):91-6. PubMed ID: 8867688
[TBL] [Abstract][Full Text] [Related]
19. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
Bodey B; Bodey V; Siegel SE; Kaiser HE
In Vivo; 2004; 18(6):713-8. PubMed ID: 15646811
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinical implication of a disintegrin and metalloprotease 8 expression in pediatric medulloblastoma.
Zhang R; Yuan Y; Zuo J; Liu W
J Neurol Sci; 2012 Dec; 323(1-2):46-51. PubMed ID: 22959284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
